Cramer's Morning Take: Eli Lilly 8/7/25
Squawk on the Street
00:00
Market Insights on Eli Lilly's Trading Strategies
This chapter explores recent trading strategies focused on Eli Lilly, particularly in light of market performance and competitive concerns in the GLP-1 sector. It discusses the decision to sell shares amid disappointing data for an oral GLP-1 medication, despite the company's otherwise positive quarterly results.
Transcript
Play full episode
